3-4-(Methylenedioxy-propiophenone CAS: 28281-49-4

CAS NO: 28281-49-4
3-4-(Methylenedioxy-propiophenone
Chemical Name: 3,4-(METHYLENEDIOXY)PROPIOPHENONE
Molecular Formula: C10H10O3
Formula Weight: 178.18
CAS No.: 28281-49-4
Description Review
Description

3-4-(Methylenedioxy-propiophenone) is a chemical compound that falls under the category of substituted phenyl-2-propanones. It's also known by other names such as MDP2P, 3,4-MDP-2-P, and Methylenedioxyphenylpropanone. This compound is used in the synthesis of various psychoactive substances such as MDMA (Ecstasy) and MDA (Sally). Its chemical name is 1-(1,3-benzodioxol-5-yl)-2-propanone, its molecular formula is C10H10O3, and its formula weight is 178.19 g/mol. Its CAS number is 28281-49-4.

Top ten keywords from Google and synonyms:

  1. MDP2P
  2. 3,4-MDP-2-P
  3. Methylenedioxyphenylpropanone
  4. Ecstasy precursor
  5. MDA precursor
  6. Benzodioxole
  7. Synthetic drugs
  8. Psychoactive substances
  9. Controlled substance
  10. Drug precursors

Health benefits of this product:

There are no known health benefits of consuming or using 3-4-(Methylenedioxy-propiophenone). In fact, it's classified as a controlled substance because of its potential for misuse and abuse. The consumption of this compound can lead to various adverse effects on the body.

Potential effects:

The consumption of 3-4-(Methylenedioxy-propiophenone) can cause various effects on the body, including:

  1. Euphoria: One of the most common effects associated with this compound is a feeling of euphoria or intense happiness.

  2. Increased sociability: Users may feel more talkative and sociable while under the influence of this compound.

  3. Increased energy: Consumption of this compound can lead to a temporary increase in energy levels.

  4. Hallucinations: In some cases, users may experience hallucinations or altered perceptions of reality.

Product mechanism:

MDP2P is a precursor to the synthesis of various psychoactive substances such as MDMA and MDA. In the production of these substances, MDP2P is converted into another chemical compound through a chemical reaction. This chemical reaction ultimately leads to the formation of MDMA or MDA.

Safety:

3-4-(Methylenedioxy-propiophenone) is a controlled substance that has the potential for misuse and abuse. Its consumption can lead to various adverse effects on the body, including neurological and cardiovascular problems. Additionally, it's important to note that its production and distribution are illegal in many countries.

Side effects:

The consumption of 3-4-(Methylenedioxy-propiophenone) can lead to various adverse effects on the body, including:

  1. Cardiovascular problems: Consumption of this compound can lead to an increased risk of heart attack, stroke, and other cardiovascular problems.

  2. Neurological problems: It can lead to neurological problems such as seizures, tremors, and even coma.

  3. Psychological problems: Individuals who consume this compound may experience anxiety, depression, paranoia, and other psychological problems.

Dosing information:

There is no recommended dose for 3-4-(Methylenedioxy-propiophenone) because of its illegal status and potential for misuse and abuse. Any consumption of this compound is considered illegal and can lead to legal repercussions.

Conclusion:

In conclusion, 3-4-(Methylenedioxy-propiophenone) is a chemical compound used in the production of various psychoactive substances such as MDMA and MDA. It's classified as a controlled substance because of its potential for misuse and abuse. Its consumption can lead to various adverse effects on the body, including neurological and cardiovascular problems. The production and distribution of this compound are illegal in many countries, and any consumption of this compound is considered illegal and can lead to legal repercussions

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code